US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, CONSIGLIO NAZIONALE DELLE RICERCHE on Aug. 4 for "RNA aptamers and use thereof for treating cancer" (American, Italian Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,502, issued on Aug. 4, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas) and CONSIGLIO NAZIONALE DELLE RICERCHE (Rome).

"RNA aptamers and use thereof for treating cancer" was invented by Anil K. Sood (Houston), Paola Amero (Houston), Gabriel Lopez-Berestein (Houston) and Vittorio De Franciscis (Rome).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are RNA aptamers targeting CD5L. Further provided herein are methods of use thereof for the treatment of a disease or disorder, such as cancer."

The patent was filed on April 1, 2021, under Application No. 17/995,343.

*For further information, including images,...